Skip to main content
B

Beijing Science Sun Pharmaceutical Co.,LTD. — Investor Relations & Filings

Ticker · 300485 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,199 across all filing types
Latest filing 2026-03-30 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300485

About Beijing Science Sun Pharmaceutical Co.,LTD.

https://www.ssyy.com.cn

Beijing Science Sun Pharmaceutical Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and marketing of biochemical medicines. The company focuses on therapeutic areas including cardiovascular and cerebrovascular diseases, immune regulation, and nervous system disorders. Its product portfolio primarily consists of injections and lyophilized powders, with key offerings such as Monosialotetrahexosylganglioside Sodium Injection, Thymopentin for injection, and various enzyme-based treatments. The company utilizes advanced biochemical extraction and purification technologies to develop high-quality pharmaceutical products. It maintains modern production facilities compliant with Good Manufacturing Practice (GMP) standards, aiming to provide effective clinical solutions for chronic and acute conditions.

Recent filings

Filing Released Lang Actions
关于2025年度利润分配预案的公告
Regulatory Filings
2026-03-30 Chinese
董事会审计委员会对会计师事务所2025年度履职情况评估及履行监督职责情况的报告
Regulatory Filings
2026-03-30 Chinese
2025年度非经营性资金占用及其他关联资金往来情况汇总表
Regulatory Filings
2026-03-30 Chinese
关于续聘公司2026年度审计机构的公告
Regulatory Filings
2026-03-30 Chinese
第五届董事会第十三次会议决议公告
Regulatory Filings
2026-03-30 Chinese
非经营性资金占用及其他关联资金往来的专项说明
Regulatory Filings
2026-03-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.